Cholestatic liver disease after small bowel transplantation failure in children.
Department of Pediatric Gastroenterology, Hopital Necker-Enfants-Malades, Paris, France.
V
V
Colomb
O J
OJ
Goulet
Y
Y
Revillon
D
D
Jan
N
N
Brousse
C
C
Rambaud
S
S
De Potter
B
B
Francois
S
S
Sarnacki
C
C
Ricour
D000961:Antilymphocyte Serum / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D002779:Cholestasis / Q000453:epidemiology*; D006084:Graft Rejection / Q000628:therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007413:Intestinal Mucosa / Q000473:pathology; D007421:Intestine, Small / Q000473:pathology / Q000637:transplantation*; D008297:Male; D016853:Muromonab-CD3 / Q000627:therapeutic use; D010289:Parenteral Nutrition, Total; D011183:Postoperative Complications; D012778:Short Bowel Syndrome / Q000601:surgery / Q000628:therapy; D017211:Treatment Failure
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3